CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.622
NA - Nord America 3.993
AS - Asia 2.818
AF - Africa 86
SA - Sud America 86
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.939
CN - Cina 1.515
GB - Regno Unito 1.242
IT - Italia 992
SG - Singapore 873
RU - Federazione Russa 500
IE - Irlanda 447
SE - Svezia 383
FR - Francia 348
DE - Germania 289
FI - Finlandia 161
VN - Vietnam 126
HK - Hong Kong 84
BR - Brasile 70
UA - Ucraina 56
NL - Olanda 48
TG - Togo 48
KR - Corea 41
BE - Belgio 38
CA - Canada 37
JO - Giordania 37
JP - Giappone 28
ID - Indonesia 26
AU - Australia 22
AT - Austria 19
CZ - Repubblica Ceca 14
IN - India 14
TR - Turchia 14
BF - Burkina Faso 12
ES - Italia 10
IR - Iran 10
PL - Polonia 10
LT - Lituania 9
CL - Cile 8
MA - Marocco 8
MX - Messico 8
PK - Pakistan 8
ZA - Sudafrica 7
BG - Bulgaria 6
LV - Lettonia 6
CH - Svizzera 5
GR - Grecia 5
KG - Kirghizistan 5
MY - Malesia 5
PA - Panama 5
CO - Colombia 4
IL - Israele 4
KE - Kenya 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
BD - Bangladesh 3
EG - Egitto 3
IQ - Iraq 3
MK - Macedonia 3
NO - Norvegia 3
PH - Filippine 3
UZ - Uzbekistan 3
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
CY - Cipro 2
EU - Europa 2
IS - Islanda 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 11.634
Salva come PNG Salva come JPEG
Città #
Southend 1.154
Chandler 945
Singapore 689
Verona 469
Dublin 413
Beijing 316
Jacksonville 245
Ann Arbor 213
Ashburn 209
Woodbridge 182
New York 168
Lawrence 134
Princeton 134
Wilmington 129
Jinan 123
Houston 98
Nanjing 92
Shenyang 88
Redmond 87
Dong Ket 82
Hong Kong 76
Helsinki 75
Sindelfingen 66
Hebei 65
Zhengzhou 57
Lomé 48
Seattle 46
Santa Clara 42
Haikou 39
Brussels 38
Ningbo 38
Amman 37
Changsha 37
Tianjin 36
Taizhou 34
Nanchang 33
Jiaxing 32
Milan 32
Guangzhou 31
Hangzhou 31
Redwood City 30
Washington 30
Dallas 29
Taiyuan 29
Dearborn 27
Seoul 27
Jakarta 26
Bologna 25
Lappeenranta 24
Munich 23
Moscow 22
Kent 21
Los Angeles 19
Shanghai 18
Tokyo 18
Vienna 18
Chicago 17
Boardman 16
Chions 16
Lancaster 16
Toronto 16
Fairfield 15
London 15
Norwalk 15
Amsterdam 13
Fuzhou 13
Bobo-Dioulasso 12
Brno 12
Falls Church 12
Sydney 12
Buffalo 10
Pieve di Soligo 10
Dongguan 9
Lanzhou 9
San Francisco 9
Falkenstein 8
Naples 8
Palermo 8
San Jose 8
Bolzano 7
Villafranca Di Verona 7
Frankfurt am Main 6
Melbourne 6
Padova 6
Riga 6
Rome 6
São Paulo 6
Trieste 6
Ajax 5
Bishkek 5
Brescia 5
Clearwater 5
Düsseldorf 5
Illasi 5
Kemerovo 5
Ottawa 5
Poznan 5
Romola 5
San Diego 5
Sofia 5
Totale 7.644
Salva come PNG Salva come JPEG
Nome #
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 293
Whole-genome landscape of pancreatic neuroendocrine tumours 174
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 172
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 170
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 148
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 145
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 137
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 137
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 136
Genomic analyses identify molecular subtypes of pancreatic cancer 134
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 126
Reporting tumor molecular heterogeneity in histopathological diagnosis 126
RON is not a prognostic marker for resectable pancreatic cancer 123
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 119
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 115
Splice variants as novel targets in pancreatic ductal adenocarcinoma 115
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 114
Genomic characterization of hepatoid tumors: context matters 112
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 108
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 107
Lost in translation: returning germline genetic results in genome-scale cancer research 106
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 105
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 104
International network of cancer genome projects 102
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 102
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 100
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 99
Research capacity. Enabling the genomic revolution in Africa 98
Gα15 in early onset of pancreatic ductal adenocarcinoma 97
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 96
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 95
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 93
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 91
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 90
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 90
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 90
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 88
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 88
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 88
Sex differences in oncogenic mutational processes 87
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 86
Biosampling and biobanking (Chapter7) 86
Hypermutation In Pancreatic Cancer 85
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 85
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 85
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 85
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 84
Building capacity for sustainable research programmes for cancer in Africa 83
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 83
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 82
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 81
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 81
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 80
Whole genomes redefine the mutational landscape of pancreatic cancer 80
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 80
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 79
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 78
Exosomal miRNA signatures of pancreatic lesions 77
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 77
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 76
Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material 75
Comparative Lesions Analysis Through a Targeted Sequencing Approach 75
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 75
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 74
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 74
The Global Genome Biodiversity Network (GGBN) Data Standard specification 73
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 73
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 73
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 72
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 72
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 72
New genomic landscapes and therapeutic targets for biliary tract cancers 71
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 71
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 71
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 71
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 69
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 69
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 68
The Italian Rare Pancreatic Exocrine Cancer Initiative 68
Genome-wide association study identifies an early onset pancreatic cancer risk locus 67
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 67
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 66
Biospecimens and Biobanking in Global Health 66
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 66
Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma 66
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 64
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 64
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 64
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 63
Reduced risk of pancreatic cancer associated with asthma and nasal allergies 63
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes 62
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 61
European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries 60
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology 60
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 59
Pan-cancer analysis of whole genomes 59
Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study 59
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 59
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 59
Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches 57
Totale 9.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.449
article - articoli 46.668
book - libri 604
conference - conferenze 744
curatela - curatele 0
other - altro 653
patent - brevetti 0
selected - selezionate 0
volume - volumi 780
Totale 98.898
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020661 0 0 0 0 0 85 123 54 39 102 125 133
2020/20211.260 180 187 75 179 140 110 35 24 43 45 90 152
2021/20221.318 127 354 75 114 52 33 54 90 51 32 81 255
2022/20232.624 160 320 203 439 219 619 45 165 291 35 89 39
2023/20241.877 57 124 125 168 177 330 95 192 56 129 305 119
2024/20252.299 298 285 329 815 309 263 0 0 0 0 0 0
Totale 12.053